These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma. Johnson GE; Monsky WL; Valji K; Hippe DS; Padia SA J Vasc Interv Radiol; 2016 Aug; 27(8):1123-9. PubMed ID: 27321889 [TBL] [Abstract][Full Text] [Related]
5. Yttrium-90 Radioembolization of Advanced, Unresectable Breast Cancer Liver Metastases-A Single-Center Experience. Pieper CC; Meyer C; Wilhelm KE; Block W; Nadal J; Ahmadzadehfar H; Willinek WA; Schild HH J Vasc Interv Radiol; 2016 Sep; 27(9):1305-1315. PubMed ID: 27461588 [TBL] [Abstract][Full Text] [Related]
6. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study. Kayaleh R; Krzyston H; Rishi A; Naziri J; Frakes J; Choi J; El-Haddad G; Parikh N; Sweeney J; Kis B J Vasc Interv Radiol; 2020 Jul; 31(7):1060-1068. PubMed ID: 32534978 [TBL] [Abstract][Full Text] [Related]
7. Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience. Memon K; Kuzel TM; Vouche M; Atassi R; Lewandowski RJ; Salem R Melanoma Res; 2014 Jun; 24(3):244-51. PubMed ID: 24638152 [TBL] [Abstract][Full Text] [Related]
8. A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases. Arulananda S; Parakh S; Palmer J; Goodwin M; Andrews MC; Cebon J Cancer Rep (Hoboken); 2019 Aug; 2(4):e1183. PubMed ID: 32721131 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma. Gabr A; Abouchaleh N; Ali R; Baker T; Caicedo J; Katariya N; Abecassis M; Riaz A; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2018 Nov; 29(11):1502-1510.e1. PubMed ID: 30268638 [TBL] [Abstract][Full Text] [Related]
10. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma. Kis B; Shah J; Choi J; El-Haddad G; Sweeney J; Biebel B; Mellon E; Frakes JM; Hoffe SE; Fishman MN; Shridhar R J Vasc Interv Radiol; 2017 Feb; 28(2):254-259. PubMed ID: 27955832 [TBL] [Abstract][Full Text] [Related]
12. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis. Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719 [TBL] [Abstract][Full Text] [Related]
13. A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis. Gonsalves CF; Eschelman DJ; Adamo RD; Anne PR; Orloff MM; Terai M; Hage AN; Yi M; Chervoneva I; Sato T Radiology; 2019 Oct; 293(1):223-231. PubMed ID: 31453767 [TBL] [Abstract][Full Text] [Related]
14. Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study. White J; Carolan-Rees G; Dale M; Patrick HE; See TC; Bell JK; Manas DM; Crellin A; Slevin NJ; Sharma RA J Vasc Interv Radiol; 2019 Aug; 30(8):1185-1192. PubMed ID: 31255499 [TBL] [Abstract][Full Text] [Related]
15. Radioembolization with Yttrium-90 Microspheres for the Treatment of Liver Metastases of Pancreatic Adenocarcinoma: A Multicenter Analysis. Kim AY; Frantz S; Brower J; Akhter N J Vasc Interv Radiol; 2019 Mar; 30(3):298-304.e2. PubMed ID: 30819469 [TBL] [Abstract][Full Text] [Related]
16. Long-Term Toxicity after Transarterial Radioembolization with Yttrium-90 Using Resin Microspheres for Neuroendocrine Tumor Liver Metastases. Tomozawa Y; Jahangiri Y; Pathak P; Kolbeck KJ; Schenning RC; Kaufman JA; Farsad K J Vasc Interv Radiol; 2018 Jun; 29(6):858-865. PubMed ID: 29724520 [TBL] [Abstract][Full Text] [Related]
17. Toxicity and Survival of Hepatocellular Carcinoma Patients with Hepatitis B Infection Treated with Yttrium-90 Radioembolization: An Updated 15-Year Study. Gao R; Gabr A; Mouli S; Riaz A; Kulik L; Lewandowski RJ; Salem R J Vasc Interv Radiol; 2020 Mar; 31(3):401-408.e1. PubMed ID: 31983593 [TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients treated with transarterial radioembolization for unresectable and chemorefractory colorectal cancer with liver metastases. Jia Z; Paz-Fumagalli R; Frey GT; Sella DM; McKinney JM; Wang W Expert Rev Gastroenterol Hepatol; 2019 Sep; 13(9):899-905. PubMed ID: 31104533 [No Abstract] [Full Text] [Related]
19. Radioembolization as salvage therapy for hepatic metastasis of uveal melanoma: a single-institution experience. Gonsalves CF; Eschelman DJ; Sullivan KL; Anne PR; Doyle L; Sato T AJR Am J Roentgenol; 2011 Feb; 196(2):468-73. PubMed ID: 21257902 [TBL] [Abstract][Full Text] [Related]
20. Survival and Toxicities after Emmons EC; Bishay S; Du L; Krebs H; Gandhi RT; Collins ZS; O'Hara R; Akhter NM; Wang EA; Grilli C; Brower JS; Peck SR; Petroziello M; Abdel Aal AK; Golzarian J; Kennedy AS; Matsuoka L; Sze DY; Brown DB Radiology; 2022 Oct; 305(1):228-236. PubMed ID: 35762890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]